Bharat Immunologicals & Biologicals Corporation Limited announced earnings results for the first quarter ended June 30, 2019. For the first quarter, the company announced total revenue was INR 88.447 million compared to INR 4.262 million a year ago. Net loss was INR 34.575 million compared to INR 8.264 million a year ago. Basic loss per share was INR 0.8 compared to INR 0.19 a year ago.